Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Cell & Bioscience

Fig. 4

From: Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer

Fig. 4

Identification of CRC-specific gene signatures across most common solid tumors. a Case numbers with genomic alterations for each gene candidate, identified in stage I/II colorectal cancer from the TCGA dataset. b The frequency of genomic alterations for each gene candidates was analyzed across nine different solid cancer types (each with >150 tumor samples) from the TCGA database

Back to article page